Peter Libby: Managing Cardiovascular Risk in Clonal Hematopoiesis of Indeterminate Potential
Peter Libby, Mallinckrodt Professor of Medicine and Cardiovascular Specialist at Harvard Medical School and Brigham and Womens Hospital, shared a post on LinkedIn:
“What do we do to address cardiovascular risk in people with clonal hematopoiesis of indeterminate potential (CHIP) in the absence of clinical trial data? In our CHIP clinic, we practice aggressive preventive cardiology tuned to the particular CHIP and traditional risk factor profile of our patients in a transparent, shared decision-making mode. We summarize some of our approach in this Primer in JACC Cardiooncology paper.
We built this experience with serial fellows who worked with me in CHIP clinic, each now faculty members: Amy Lin UCSF, Aeron Small MGB/Harvard, and Ohad Oren Cleveland Clinic, who took the lead in this report. I’m proud of their successes! Nicholas Chiu is my current fellow, joining this lineage. Now we need to work together to generate the data to fill the evidence gap in managing CHIP!”
Title: Managing Cardiovascular Risk in Clonal Hematopoiesis of Indeterminate Potential: JACC: CardioOncology Short-Form Primer
Authors: Ohad Oren, Aeron M. Small, Amy E. Lin, Peter Libby
Read full paper here.
Stay updated with Hemostasis Today.
-
Nov 10, 2025, 10:16Pablo Corral on Enlicitide: The Phase 3 CORALreef HeFH Trial Brings a Major Step Forward
-
Nov 10, 2025, 10:15Laurent Bertoletti Invites You to the Joint INNOVTE and GITA Meeting on Hormones and Thrombosis
-
Nov 10, 2025, 10:15Christopher Cannon: DOAC Monotherapy Wins Again
-
Nov 10, 2025, 10:14Marieke Kruip on Sex differences in Outcomes of VKA Treatment in Patients with Mechanical Heart Valve
-
Nov 10, 2025, 10:14Ana Paula Lacombe: From Research to Bedside, Innovation in Stroke Care is Moving Fast!
-
Nov 10, 2025, 10:13Jan Sloves: Understanding Iliofemoral DVT – What You Can’t Afford to Miss
-
Nov 10, 2025, 10:12Mohamed Rawy Shares a Comprehensive Guide For Anticoagulation
-
Nov 10, 2025, 10:10Marc Carrier: Proud to Share the Results of the WAVe Study
-
Nov 10, 2025, 10:07Frederik Denorme – The New PI at the Laboratory of Cell Biology and Histology at University of Antwerp